| Mr John Stephen Blackburn, CRNA | |
|
7210g Broad River Rd, Irmo, SC 29063-7972 | |
| (803) 407-5266 | |
| Not Available |
| Full Name | Mr John Stephen Blackburn |
|---|---|
| Gender | Male |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 7210g Broad River Rd, Irmo, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164490801 | NPI | - | NPPES |
| 11770 | Other | TN | APN |
| 60552 | Other | TN | RN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 11770 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr John Stephen Blackburn, CRNA Po Box 1637, Irmo, SC 29063-1637 Ph: (803) 407-5266 | Mr John Stephen Blackburn, CRNA 7210g Broad River Rd, Irmo, SC 29063-7972 Ph: (803) 407-5266 |
News Archive
New Danish-led research suggests that signs of brain aging can be postponed in mice if placed on a high-fat diet. In the long term, this opens the possibility of treatment of children suffering from premature aging and patients with Alzheimer's and Parkinson's disease. The research project is headed by the Center for Healthy Aging, University of Copenhagen and the National Institute of Health.
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment.
Researchers at the medical university Karolinska Institutet have created a genetically modified mouse in which certain neurons can be activated by blue light. Shining blue light on brainstems or spinal cords isolated from these mice produces walking-like motor activity. The findings, which are published in the scientific journal Nature Neuroscience, are of potential significance to the recovery of walking after spinal cord injury.
The Case Management Society of America (CMSA) and DMAA: The Care Continuum Alliance (DMAA) are working together to strengthen and define the relationship between health care "case management" and "population health management" interventions.
Arena Pharmaceuticals, Inc. reported today data from the pivotal BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) Phase 3 trial that demonstrate improvements in patients' body composition, cardiovascular risk factors and quality of life. These findings add to the previously announced top-line BLOSSOM data that showed highly significant weight loss with lorcaserin over one year of treatment in 4,008 patients.
› Verified 1 days ago
Ms. Sharon K. Harmon, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1 Wellness Blvd, Suite 110, Irmo, SC 29063 Phone: 843-839-5995 |